A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry or Sensitive Skin

Inclusion Criteria: * Age: 18 to 55 years (both inclusive) at the time of consent. * Sex: Healthy male and non-pregnant/non-lactating females. * Females of childbearing potential must have a self-reported negative pregnancy test. * Subject are generally in good health. * Subject with dry or sensitive skin at a time of screening. (Dermatological Assessment) * Subjects assessment site must be free of cuts, tattoos, scratches, abrasions, scars, uneven skin tone, sunburn, excessive tan, excessive hair or open wounds. * Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study. * If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation. * Subjects are willing to give written informed consent and are willing to come for regular follow up. * Subjects who commit not to use medicated skincare products other than the test product for the entire duration of the study. * Subject who have not participated in a similar investigation in the past three months. * Willing to use test product throughout the study period. Exclusion Criteria: * History of any dermatological condition of the skin diseases. * Subject with present condition of allergic response to any cosmetic product. * Subject having allergic response to the ink. * Presence of any broken, chapped, cut, irritated, or scraped skin at the application site. * Subjects under chronic medication (e.g. aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy etc.) that might influence the outcome of the study. * Subject having acne of severe incidence (presence of nodules, cysts or numerous pustules) which requires pharmaceutical or cosmeceuticals, herbal treatment. * Subjects who have applied topical treatment for at least 4 weeks and any systemic treatment for at least 3 months, before they participated in the study. * History of alcohol or drug addiction. * Subjects using other marketed products during the study period. * Any other condition which could warrant exclusion from the study, as per the dermatologist's/investigator's discretion. * Pregnant or breastfeeding or planning to become pregnant during the study period. * History of chronic illness which may influence the cutaneous state. * Subjects participating in other similar cosmetics, devices or therapeutic trials or skincare products within the last four weeks.